Stroke: meta-analysis finds better outcomes from endovascular treatment

Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • A meta-analysis suggests that endovascular treatment is associated with favorable or excellent outcomes compared with best medical treatment in patients with acute ischemic stroke.

Study design

  • 15 randomized trials, including 2980 patients, that compared endovascular treatment with best medical treatment were subjected to meta-analysis, with a primary endpoint of outcome by modified Rankin scale.

Key results

  • Patients who received endovascular treatment had significantly higher rates of favorable outcomes (OR=1.82 [95% CI, 1.38-2.40], P<.001) and excellent outcomes (OR=1.77 [95% CI, 1.29-2.43], P<.001).
  • Patients who received endovascular treatment and patients who received best medical treatment had similar risk of symptomatic intracranial hemorrhage (OR=1.19 [95% CI, 0.84-1.68], P=.34).

Why this matters

  • Randomized trials assessing the efficacy of endovascular treatment have shown conflicting results.